In the last trading session, 3.11 million shares of the Atossa Therapeutics Inc. (NASDAQ:ATOS) were traded, and its beta was 1.17. Most recently the company’s share price was $0.84, and it changed around $0.11 or 15.02% from the last close, which brings the market valuation of the company to $106.11M. ATOS currently trades at a discount to its 52-week high of $1.36, offering almost -61.9% off that amount. The share price’s 52-week low was $0.50, which indicates that the current value has risen by an impressive 40.48% since then. We note from Atossa Therapeutics Inc.’s average daily trading volume that its 10-day average is 0.59 million shares, with the 3-month average coming to 304.31K.
Atossa Therapeutics Inc. (NASDAQ:ATOS) trade information
Instantly ATOS has showed a green trend with a performance of 15.02% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 0.8800 on Tuesday, 05/23/23 increased the stock’s daily price by 4.55%. The company’s shares are currently up 58.56% year-to-date, but still up 17.53% over the last five days. On the other hand, Atossa Therapeutics Inc. (NASDAQ:ATOS) is 24.70% up in the 30-day period. We can see from the shorts that 8.07 million shares have been sold at a short interest cover period of 29.19 day(s).
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
The consensus price target as assigned by Wall Street analysts is $4.75, which translates to bulls needing to increase their stock price by 82.32% from its current value. Analyst projections state that ATOS is forecast to be at a low of $4.00 and a high of $5.50. In order for the stock price to hit the forecast high, the stock would need to plunge -554.76% from its current level, while the stock would need to crash -376.19% from its current level to reach the projected low.
Atossa Therapeutics Inc. (ATOS) estimates and forecasts
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 54.50%.
ATOS Dividends
Atossa Therapeutics Inc.’s next quarterly earnings report is expected to be released around August 07 and August 11.
Atossa Therapeutics Inc. (NASDAQ:ATOS)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.04% of Atossa Therapeutics Inc. shares, and 20.66% of them are in the hands of institutional investors. The stock currently has a share float of 20.67%. Atossa Therapeutics Inc. stock is held by 62 institutions, with Vanguard Group, Inc. (The) being the largest institutional investor. By Mar 30, 2023, it held 4.50% of the shares, which is about 5.7 million shares worth $4.13 million.
Blackrock Inc., with 2.53% or 3.2 million shares worth $2.32 million as of Mar 30, 2023, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 30, 2022. The former held 3.78 million shares worth $2.0 million, making up 2.98% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 1.69 million shares worth around $0.89 million, which represents about 1.33% of the total shares outstanding.
